BARINTHUS BIOTHERAPEUTICS PLC - AMERICAN DEPOSITAR
1.4200
05-July-24 14:19:25
15 minutes delayed
Stocks
-0.0100
-0.70%
Today's range
1.3900 - 1.4300
ISIN
N/A
Source
NASDAQ
-
Vaccitech Appoints Industry Veteran, Nadège Pelletier, Ph.D., as Chief Scientific Officer
30 Jan 2023 08:00:01 By Nasdaq GlobeNewswire
-
21 Nov 2022 10:31:34 By Nasdaq GlobeNewswire
-
Vaccitech Reports Third Quarter 2022 Financial Results and Recent Corporate Developments
10 Nov 2022 16:30:00 By Nasdaq GlobeNewswire
-
Vaccitech to Present at Upcoming November Investors Conferences
09 Nov 2022 08:00:01 By Nasdaq GlobeNewswire
-
07 Nov 2022 08:00:02 By Nasdaq GlobeNewswire
-
02 Nov 2022 08:00:02 By Nasdaq GlobeNewswire
-
31 Oct 2022 08:00:02 By Nasdaq GlobeNewswire
-
27 Oct 2022 07:00:01 By Nasdaq GlobeNewswire
-
Vaccitech to Present at Upcoming October Investor & Scientific Conferences
03 Oct 2022 16:30:00 By Nasdaq GlobeNewswire
-
Vaccitech Promotes Gemma Brown as Chief Financial Officer
20 Sep 2022 16:30:00 By Nasdaq GlobeNewswire
-
Vaccitech to Present at Upcoming September Investors Conferences
07 Sep 2022 16:01:00 By Nasdaq GlobeNewswire
-
Vaccitech Reports Second Quarter 2022 Financial Results and Recent Corporate Developments
09 Aug 2022 16:15:00 By Nasdaq GlobeNewswire
-
Vaccitech to Present at the William Blair Biotech Focus Conference 2022
07 Jul 2022 16:15:00 By Nasdaq GlobeNewswire
-
Vaccitech to Present at the Jefferies Healthcare Conference
06 Jun 2022 16:15:00 By Nasdaq GlobeNewswire
-
06 Jun 2022 07:32:00 By Nasdaq GlobeNewswire
-
Vaccitech to Present at the H.C. Wainwright Global Investment Conference
20 May 2022 11:30:00 By Nasdaq GlobeNewswire
-
Vaccitech Reports First Quarter 2022 Financial Results and Recent Corporate Developments
11 May 2022 16:15:00 By Nasdaq GlobeNewswire
-
Vaccitech Announces Notification of Milestone and Royalty Revenue Relating to Sales of Vaxzevria®
06 Apr 2022 16:15:00 By Nasdaq GlobeNewswire